Anti-GLP1 antibody [9F8] (ab23447)


  • Product nameAnti-GLP1 antibody [9F8]
    See all GLP1 primary antibodies
  • Description
    Mouse monoclonal [9F8] to GLP1
  • Specificityab23447 recognises low activity enzyme GLP1. No crossreactitvity with either activated forms GLP1 (7-36) amide or GLP1 (7-37) amide.
  • Tested applicationsSuitable for: ELISA, WB, IHC-Frmore details
  • Species reactivity
    As GLP1 is identical across all mammals studied the antibody is expected to cross-react with GLP1 from all mammals.
  • Immunogen

    Synthetic peptide coupled to diphtheria toxoid with glutaraldehyde.

  • EpitopeThe epitope is located in the region of residues 1-6 of GLP1.



Our Abpromise guarantee covers the use of ab23447 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA 1/16000.
WB Use at an assay dependent concentration.
IHC-Fr Use at an assay dependent concentration.


  • FunctionGlucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes.
    GLP-1 is a potent stimulator of glucose-dependent insulin release. Play important roles on gastric motility and the suppression of plasma glucagon levels. May be involved in the suppression of satiety and stimulation of glucose disposal in peripheral tissues, independent of the actions of insulin. Have growth-promoting activities on intestinal epithelium. May also regulate the hypothalamic pituitary axis (HPA) via effects on LH, TSH, CRH, oxytocin, and vasopressin secretion. Increases islet mass through stimulation of islet neogenesis and pancreatic beta cell proliferaton. Inhibits beta cell apoptosis.
    GLP-2 stimulates intestinal growth and up-regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. The gastrointestinal tract, from the stomach to the colon is the principal target for GLP-2 action. Plays a key role in nutrient homeostasis, enhancing nutrient assimilation through enhanced gastrointestinal function, as well as increasing nutrient disposal. Stimulates intestinal glucose transport and decreases mucosal permeability.
    Oxyntomodulin significantly reduces food intake. Inhibits gastric emptying in humans. Suppression of gastric emptying may lead to increased gastric distension, which may contribute to satiety by causing a sensation of fullness.
    Glicentin may modulate gastric acid secretion and the gastro-pyloro-duodenal activity. May play an important role in intestinal mucosal growth in the early period of life.
  • Tissue specificityGlucagon is secreted in the A cells of the islets of Langerhans. GLP-1, GLP-2, oxyntomodulin and glicentin are secreted from enteroendocrine cells throughout the gastrointestinal tract. GLP1 and GLP2 are also secreted in selected neurons in the brain.
  • Sequence similaritiesBelongs to the glucagon family.
  • Post-translational
    Proglucagon is post-translationally processed in a tissue-specific manner in pancreatic A cells and intestinal L cells. In pancreatic A cells, the major bioactive hormone is glucagon cleaved by PCSK2/PC2. In the intestinal L cells PCSK1/PC1 liberates GLP-1, GLP-2, glicentin and oxyntomodulin. GLP-1 is further N-terminally truncated by post-translational processing in the intestinal L cells resulting in GLP-1(7-37) GLP-1-(7-36)amide. The C-terminal amidation is neither important for the metabolism of GLP-1 nor for its effects on the endocrine pancreas.
  • Cellular localizationSecreted.
  • Information by UniProt
  • Alternative names
    • GCG antibody
    • glicentin-related polypeptide antibody
    • GLP-1 antibody
    • GLP-1(7-36) antibody
    • GLP-1(7-37) antibody
    • GLP-2 antibody
    • GLP1 antibody
    • GLP1, included antibody
    • GLP2 antibody
    • GLP2, included antibody
    • GLUC_HUMAN antibody
    • Glucagon antibody
    • Glucagon like peptide 1 antibody
    • glucagon-like peptide 1 antibody
    • Glucagon-like peptide 1, included antibody
    • Glucagon-like peptide 2 antibody
    • Glucagon-like peptide 2, included antibody
    • GRPP antibody
    • OXM antibody
    • OXY antibody
    • preproglucagon antibody
    see all

Anti-GLP1 antibody [9F8] images

  • ab23447 at a 1/500 dilution staining GLP1 from frozen sections of human GI tract by immunohistochemistry. An HRP conjugated anti-mouse antibody was used as the secondary reagent.

    This image is courtesy of an Abreview submitted by an anonymous researcher on 8 December 2005.

    See Abreview

References for Anti-GLP1 antibody [9F8] (ab23447)

ab23447 has not yet been referenced specifically in any publications.

Product Wall

Application Immunohistochemistry (Frozen sections)
Sample Human Tissue sections (GI tract)
Specification GI tract
Blocking step Serum as blocking agent for 30 minute(s) · Concentration: 1

Abcam user community

Verified customer

Submitted Feb 08 2006

Thank you for your enquiry. The concentration of this antibody is 1 mg/mL. Should you require further assistance, please do not hesitate to contact me.

Thank you for your enquiry. ab23447 is specific for the low activity enzyme GLP-1(1-36)amide, but not with either of the activated forms GLP-1(7-36)amide and GLP-1(7-37)amide. You may find the paper below useful for further information on in the ...

Read More